Sponsors help fuel the growth of our mission.
They share in our common interests or participate in achieving a common goal. They can have multi-year, long-term strategic agreements and commitments or support an event, project, item, or activity through funding or by provisioning of products.
We welcome sponsorships, but at no time can they influence, or attempt to influence, the science of our efforts, presentations, and findings, etc. Sponsor agreements are in no way an endorsement by the College of their products, services, policies, science, innovations, or initiatives. We do not endorse sponsor products, services, policies, science, innovations or initiatives.
Abbott Point of Care develops, manufactures and markets critical medical diagnostic and data management products for rapid blood analysis. The company's premier product, the i-STAT System, is a market-leading handheld device capable of performing a broad menu of tests, including cardiac markers; blood gases; coagulation; lactate; chemistries/electrolytes; and hematology, using two or three drops of blood at the patient's side.
Apex Innovations is an international leader in online programs, built with Intelligent Interactivity®, to help you easily accomplish required provider education. imPULSE® 2.0 - ECG and Chest Pain Competency Series, Hemispheres® — Stroke Competency Series, Responder® — STEMI Recognition, Transitions®. Educate more efficiently and economically with online programs giving you comprehensive and current education. Meet professional requirements for certification and competency, includes accountability measures and clinical practice guidelines. Includes testing, CE credit, reporting, benchmarking and 24/7 tech support.
Critical Diagnostics develops novel biomarkers to help physicians optimize patient care in cardiovascular diseases, while containing healthcare costs.
Their lead product, the Presage® ST2 Assay, has received FDA clearance and is CE Marked in Europe. This simple, non-invasive test measures for soluble ST2 in the blood, can aid physicians in risk assessment of chronic heart failure patients.
ST2 is a soluble protein expressed by the heart in response to disease or injury. It is reflective of ventricular remodeling and cardiac fibrosis associated with heart failure. ST2 is not adversely affected by confounding factors such as age, body mass index and impaired renal function. Unlike many other cardiac biomarkers, ST2 levels change quickly in response to changes in the patient's condition thus helping physicians make informed decisions on an appropriate course of action to take and, if needed, to quickly adjust treatment.
The 2013 ACC/AHA Guideline for the Management of Heart Failure, recognizes ST2 as 3not only predictive of hospitalization and death in patients with HF but also additive to natriuretic peptide levels in [its] prognostic value.2
Mitsubishi Chemical USA, Inc. brings the PATHFAST® cardiac bio marker analyzer and its precision and accuracy to the US market. With its 17 minute assay turnaround time and 99th percentile, guideline acceptable Troponin results available at point-of-care, the PATHFAST will help caregivers improve patient outcomes and save lives.
Learn more about PATHFAST.